(ÒýÓà mltt:°®¹úÈÈÇéÊÇÕæµÄ666)Æäʵ´ó¼ÒÖ÷ÒªÊǾõµÃ´òÁË¿ÆÐË£¬»Ø¹úû×è°¿¼Âǵ½ÃÀ¹ú·¨¹úµÈÎ÷·½¹ú¼Ò¶¼²»³ÐÈÏ¿ÆÐËÒßÃ磬ºÜ¿ÉÄÜÖйú»á¶ÔµÈ²»³ÐÈÏ»ÔÈðĪµÂÄÉÒßÃç¡£Ïë»Ø¹ú¿Ï¶¨ÊÇ¿ÆÐË°²È«Ð©¡£
µ±È»Èç¹ûÓð®¹úÕâÖÖ¸ßñ×ÓÀ´ÑÚ¸ÇÐÄÀïµÄСËãÅÌ£¬ºÎÀÖ¶ø²»ÎªÄØ[ÌìÑĺ£½Ç¸ÕºÃ (6-20 7:42, Long ago)]
[ ´«Í³°æ |
sForum ][µÇ¼ºó»Ø¸´]41Â¥
(ÒýÓà ÌìÑĺ£½Ç¸ÕºÃ:Æäʵ´ó¼ÒÖ÷ÒªÊǾõµÃ´òÁË¿ÆÐË£¬»Ø¹úû×è°¿¼Âǵ½ÃÀ¹ú·¨¹úµÈÎ÷·½¹ú¼Ò¶¼²»³ÐÈÏ¿ÆÐËÒßÃ磬ºÜ¿ÉÄÜÖйú»á¶ÔµÈ²»³ÐÈÏ»ÔÈðĪµÂÄÉÒßÃç¡£Ïë»Ø¹ú¿Ï¶¨...)ÎÒÈÏʶµÄ¶¼ÊÇÅÂÆäËû¼¸¿îµÄ¸±×÷ÓÃÁíÍ⻹ÓÐЩÓÌÔ¥´ò²»´òÒßÃçµÄ£¬ÊÇÅÂADE¡£
¿ÉÄÜÎÒµÄȦ×ÓÌ«ÕÁË
¡¡[±¾ÎÄ·¢ËÍ×Ô»ªÐÂiOS APP]
[Calicocat (6-20 8:01, Long ago)]
[ ´«Í³°æ |
sForum ][µÇ¼ºó»Ø¸´]42Â¥
(ÒýÓà Calicocat:ÎÒÈÏʶµÄ¶¼ÊÇÅÂÆäËû¼¸¿îµÄ¸±×÷ÓÃÁíÍ⻹ÓÐЩÓÌÔ¥´ò²»´òÒßÃçµÄ£¬ÊÇÅÂADE¡£
¿ÉÄÜÎÒµÄȦ×ÓÌ«ÕÁË)ºÍÄã·ÖÏíÒ»¸öºÃÏûÏ¢¡«×îз¢±íÔÚcellµÄpaper±íÃ÷йڲ¡¶¾µÄ¿¹Ìå²»»á²úÉúADEЧӦŶ£¬ËùÒÔ¿ÉÒÔ·ÅÐÄ´òÒßÃçÁË£¡
ÂÛÎÄÐÅÏ¢ÔÚ´Ë£º
In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing
antibodies
https://doi.org/10.1016/j.cell.2021.06.021[СÆÐÌá (6-20 11:31, Long ago)]
[ ´«Í³°æ |
sForum ][µÇ¼ºó»Ø¸´]43Â¥
²»¹ýÖйúÒ²ÓÐÐèÒª¸Ä½øµÄµØ·½ÎÒ¾õµÃÖйúÕþ¸®Ó¦¸Ã³Ö¿ÆѧµÄ̬¶È£¬»¨¸ü¶à¾«Á¦ÔÚÊý¾ÝÊý¾ÝµÄ¹«²¼ºÍ½âÊÍÉÏ¡£ËäÈ»¹úÄÚ¿¹Òߺܳɹ¦£¬µ«ÊÇÐû´«£¬ÓÈÆäÊǹúÍâµÄÐû´«ºÍÈÏ¿ÉÊǺÜÓÐÏ޵ġ£ÒòΪÄÄźܶàÔÚ¹úÍâµÄÖйúÈË£¬¶¼¶ÔÖйúÒßÃç³Ö»³ÒÉ̬¶È¡£
¾¡¹ÜÏÖÔÚÔںܶ෢չÖйú¼Ò£¬ÖйúÒßÃçµÃµ½ºÜ´ó¹æÄ£µÄʹÓ㬵«Õâ²»×ãÒÔÓ°ÏìÈËÃǶÔÖйúµÄÓ¡Ïó¡£Èç¹ûÄÜÔÚÏã¸Û£¬Ð¼ÓƵȵõ½¸ü´óÈÏ¿É£¬ÎÒ¾õµÃÕâ²ÅÊÇÒ»¸öÍ»ÆÆ¡£
ÎÒ¾õµÃ°²È«ÐÔÊÇ´«Í³ÒßÃçµÄºÃ´¦¡£¸öÈËÀí½â£¬´¥·¢ÌåÄÚµÖ¿¹Òò×ÓԽǿµÄÒßÃ磬±£»¤Á¦¾ÍÔ½´ó¡£Õâ¾ÍÊÇΪʲômRNAµÄ±£»¤Á¦¿ÉÄܸüÇ¿£¬µ«²úÉúµÄ²»Á¼·´Ó¦Ò²Ô½´ó¡£ºÜ¶àÈË´òÍêÒßÃç¾ÍËÀÈ¥µÄÀý×Ó£¬¶¼Ã»Óб»µ±¾ÖÈ϶¨ÎªÊÇÒßÃçµÄ×÷Ó㬿ÉÄܸü¶àµÄ³öÓÚµ±Ç°µÄ¿¹ÒßÐèÒª¡£µ±¾Ö²»¿ÉÄÜΪÁËÒ»Á£ÀÏÊóʺ»ÙµôÒ»¹øÖà¡£µ«ÄãÒ²ÐíÒ²¿´µ½×î½üÒ»ÔòÐÂÎÅ£¬Òâ´óÀûÒ»Ãû18ËêÅ®×Ó´òÍ갢˹Àû¿µµÃѪ˨ËÀÈ¥£¬Á¢ÂíÓйÙÔ±ÌáÒé±ØÐë½ûÖ¹´ò°¢Ë¹Àû¿µÒßÃ磬Õâ²ÅÊǶÔÉúÃü×î¸ßµÄ×ðÖØ£¬µ«ºÜ¶à¹ú¼ÒÏÖÔÚ²»¿ÉÄÜÕâÑù×ö£¬ÄÇÊÇÐèÒª¼«´óµÄ¾¼Ã´ú¼ÛµÄ¡£
´«Í³ÒßÃçÏà¶Ôκͣ¬Ã»±ØÒªÒòΪËüÊÇÖйúµÄÖ÷´ò²úÆ·¾Í·ñÈÏËü¡£Öйú¿Æѧ¼ÒµÄ̬¶ÈºÍ±ê×¼£¬ÊÇÖµµÃÊÀ½ç¹ÎÄ¿Ïà¿´µÄ¡£Èç¹ûмÓÆ¿ª·¢ÁË´«Í³ÒßÃ磬ÎÒÒ²»á³¢ÊԵġ£
¡¡[±¾ÎÄ·¢ËÍ×Ô»ªÐÂÊÖ»úWap°æ]
[»¨ÎÞȱÓëСÓã¶ù (6-20 7:51, Long ago)]
[ ´«Í³°æ |
sForum ][µÇ¼ºó»Ø¸´]44Â¥
(ÒýÓà »¨ÎÞȱÓëСÓã¶ù:²»¹ýÖйúÒ²ÓÐÐèÒª¸Ä½øµÄµØ·½ÎÒ¾õµÃÖйúÕþ¸®Ó¦¸Ã³Ö¿ÆѧµÄ̬¶È£¬»¨¸ü¶à¾«Á¦ÔÚÊý¾ÝÊý¾ÝµÄ¹«²¼ºÍ½âÊÍÉÏ¡£ËäÈ»¹úÄÚ¿¹Òߺܳɹ¦£¬µ«ÊÇÐû´«£¬ÓÈÆä...)Äã˵µÃ¶Ô°¢Ë¹Àû¿µ¿ÉÄÜÒý·¢ÑªË¨£¬Ð¼ÓÆÂÕþ¸®²¢Ã»ÓÐÒòΪËüÊÇÓ¢¹úµÄ¾ÍäĿÒý½ø£¬Õâ¾ÍÊÇ¿ÆѧµÄ̬¶È£¬³¬Ô½ÁËÕþÖΡ£Ó¢¹úÈËËƺõҲûÓжÔÕâ¸öÇ°Ö³ÃñµØÊ©¼ÓÕþÖÎѹÁ¦¡£[ÌìÑĺ£½Ç¸ÕºÃ (6-20 7:59, Long ago)] [ ´«Í³°æ | sForum ][µÇ¼ºó»Ø¸´]45Â¥
(ÒýÓà »¨ÎÞȱÓëСÓã¶ù:²»¹ýÖйúÒ²ÓÐÐèÒª¸Ä½øµÄµØ·½ÎÒ¾õµÃÖйúÕþ¸®Ó¦¸Ã³Ö¿ÆѧµÄ̬¶È£¬»¨¸ü¶à¾«Á¦ÔÚÊý¾ÝÊý¾ÝµÄ¹«²¼ºÍ½âÊÍÉÏ¡£ËäÈ»¹úÄÚ¿¹Òߺܳɹ¦£¬µ«ÊÇÐû´«£¬ÓÈÆä...)ÄãµÄ¼¸¸ö»Ø¸´ÍêÈ«Ô޳ɡ£Ð¼ÓÆÂÕþ¸®µÄ¿¼Á¿£¬¾ÍÄÇô»ØÊÂÁË£¬ÎÞÂÛÇ×ÃÀÇ×Öл¹ÊÇÇ×еģ¬Ö»ÒªÁ˽âмÓƵģ¬¶¼»áÃ÷°×Õâ²»µ¥µ¥ÊDZíÃæ¿´µ½µÄ¡£
µ±È»×îºóÒ»¾ä£¬Ð¼ÓÆ¿ª·¢ÒßÃ磿ʵÌåÐÐÒµ»¹ÊÇËãÁË°É£¬Ð¼ÓÆÂÄÜ¿ª·¢³öÒßÃ磬ºïÄêÂíÔ¹À¼ÆÒ²µÈ²»µ½°¡¡£
¡¡[±¾ÎÄ·¢ËÍ×Ô»ªÐÂÊÖ»úWap°æ]
[andy99 (6-20 8:07, Long ago)]
[ ´«Í³°æ |
sForum ][µÇ¼ºó»Ø¸´]46Â¥
Òª½¨ÒßÃ糧ÁË£¬¾ö²»ÄÜ×Ô»ÙÃûÉù£¬
mRNAµÄ±£»¤ÂʸßÕâÊÇÒßÃç±¾Öʾö¶¨µÄ£¬°ÐÏòÒßÃ磬¿ÉÒÔ¾«×¼Ìá¸ß¿¹ÌåµÎ¶È£¬µ«ÊÇ×¥µãÉÙ£¬Ãæ¶Ô±äÒìÒ»µ©×¥µãÎÞЧ£¬±ØÐëÖØб༡£
¶ÔÓÚdalta±äÒìÎÄÏ×ÊǽµµÍ6±¶£¬µ«¾ßÌåÊǶàÉٰٷֱÈ×Ô¼ºÏëÏó£¬Ð¼ÓƵÄ70%±£»¤ÂÊÊÇÏÖÔÚÌõ¼þϵĽá¹û£¬ÒòΪ±£»¤ÂʼÆËãÐèÒªÔÚ³ä·Ö±©Â¶µÄÌõ¼þÏ£¬³ä·Ö±©Â¶ºÜÖØÒª£¬ÖØÒªµÄÊÂҪ˵Èý±é£¬³ä·Ö±©Â¶£¬
ÕýÊÇÓÉÓÚ¸÷¹úµÄÒßÇéµÄ´ëÊ©²»Í¬£¬Ôì¾ÍÁ˳ä·Ö±©Â¶Ìõ¼þ²»Ò»Ö£¬ËùÒÔ¿ÆÐËÒßÃçÔÚ¸÷¹ú±£»¤Âʲ»Ò»Öµ«×î²îµÄÒ²³¬¹ý50%£¬
×î¹Ø¼üµÄÊÇÃð»îÒßÃç×¥µã¶à¿ÉÒÔÓ¦¶Ô²¡¶¾±äÒ죬¶øÇÒÄܹ»´úлÅųö¡£
×îÖØÒªµÄÒßÃçÊÇÎïÀí¸ôÀëµÄ¸¨Öú£¬¶ø²»ÊÇÏà·´£¬[lgland (6-20 8:07, Long ago)]
[ ´«Í³°æ |
sForum ][µÇ¼ºó»Ø¸´]47Â¥
(ÒýÓà lgland:Òª½¨ÒßÃ糧ÁË£¬¾ö²»ÄÜ×Ô»ÙÃûÉù£¬
mRNAµÄ±£»¤ÂʸßÕâÊÇÒßÃç±¾Öʾö¶¨µÄ£¬°ÐÏòÒßÃ磬¿ÉÒÔ¾«×¼Ìá¸ß¿¹ÌåµÎ¶È£¬µ«ÊÇ×¥µãÉÙ£¬Ãæ¶Ô±äÒìÒ»µ©×¥µãÎÞÐ...)Õþ¸®µÄ˵·¨ÓÐÒâ˼£¬¿ª·Å¿ÆѧΪÄÇЩ²»ÄÜ´ò»ÔÈðµÄÌض¨ÈËȺ´ò£¬
ÓÐÒâ˼£¬Ç±Ì¨´ÊµÄ°²È«³Ì¶È²»ÑÔ¶øÓ÷£¬
¶ÔÓÚÔи¾´òÒßÃçµÄ½¨ÒéÓеã²ÝÂÊ£¬[lgland (6-20 8:16, Long ago)]
[ ´«Í³°æ |
sForum ][µÇ¼ºó»Ø¸´]48Â¥
(ÒýÓà lgland:Òª½¨ÒßÃ糧ÁË£¬¾ö²»ÄÜ×Ô»ÙÃûÉù£¬ mRNAµÄ±£»¤ÂʸßÕâÊÇÒßÃç±¾Öʾö¶¨µÄ£¬°ÐÏòÒßÃ磬¿ÉÒÔ¾«×¼Ìá¸ß¿¹ÌåµÎ¶È£¬µ«ÊÇ×¥µãÉÙ£¬Ãæ¶Ô±äÒìÒ»µ©×¥µãÎÞÐ...)¸çÃǶùÄúÕæÓÐÒãÁ¦ºÍÕâ°ïÀ¬»ø¶·×ì ¡¡[±¾ÎÄ·¢ËÍ×Ô»ªÐÂiOS APP] [¹úÍõ´óµÀ (6-20 9:04, Long ago)] [ ´«Í³°æ | sForum ][µÇ¼ºó»Ø¸´]49Â¥
(ÒýÓà ¹úÍõ´óµÀ:¸çÃǶùÄúÕæÓÐÒãÁ¦ºÍÕâ°ïÀ¬»ø¶·×ì)ÂýÂýÎÒÒ²¿´Ã÷°×ÁË[ESPRITEE (6-20 12:04, Long ago)] [ ´«Í³°æ | sForum ][µÇ¼ºó»Ø¸´]50Â¥
(ÒýÓà ¹úÍõ´óµÀ:¸çÃǶùÄúÕæÓÐÒãÁ¦ºÍÕâ°ïÀ¬»ø¶·×ì)¹þ¹þ£¬ÎÒ¸ÕÒ²Ïë˵Õâ¾ä»°Covid19Ôç´ÓÀí¿Æ¿¼¾í±äÎÄ¿Æ¿¼¾í£¬ÏÖÔÚ´ó¸ÅÊÇÒÕÊõÌØÕÐÁË¡£ ¡¡[±¾ÎÄ·¢ËÍ×Ô»ªÐÂiOS APP] [Calicocat (6-20 12:31, Long ago)] [ ´«Í³°æ | sForum ][µÇ¼ºó»Ø¸´]51Â¥
ƽʱ¹ØעһЩýÌ壬ʱ¼ä¾ÃÁ˾ÍÄÜÖªµÀËûÃǵÄÑÔÂÛÇãÏòyahoo SingaporeÎÒ¹Ø×¢ºÜ¾ÃÁË£¬¿ÉÒÔ˵±ÈмÓƱ¾µØýÌå·´HµÃ¶à£¬ËùÒÔËûÃǸã³öÕâÖÖ±êÌ⣬ºÁ²»ÒâÍâ¡£ ¡¡[±¾ÎÄ·¢ËÍ×Ô»ªÐÂÊÖ»úWap°æ] [Seabass (6-20 8:27, Long ago)] [ ´«Í³°æ | sForum ][µÇ¼ºó»Ø¸´]52Â¥
ÏëÆðÇ°¼¸ÌìÂÛ̳ÓÐÈËÌáµÄ¡£ÎþÉüÒ»È˾ȰÙÈ˵ÄÎÊÌâ×÷ΪҪ¿¼ÂÇ£¬¾¼Ã£¬ÕþÖεÄzf£¬¾ÍÊÇÒª¿¼ÂÇ°ÙÈË£¬ÍòÈË£¬°ÙÍòÈË
×÷Ϊ¸öÌ壬¶¼²»Ïë³ÉΪһ¸öÈË£¬ÄÄÅÂÊÇÈκÎDZÔÚ»ú»á³ÉΪÄÇÒ»¸öÈË¡£
¡¡[±¾ÎÄ·¢ËÍ×Ô»ªÐÂÊÖ»úWap°æ]
[Seabass (6-20 8:32, Long ago)]
[ ´«Í³°æ |
sForum ][µÇ¼ºó»Ø¸´]53Â¥
°®¹úÓ¦¸Ã´ò³¤ÉúÉúÎïµÄÒßÃ磬ºÈÈý¹ÄÌ·Û[cici0626 (6-20 9:51, Long ago)] [ ´«Í³°æ | sForum ][µÇ¼ºó»Ø¸´]54Â¥
mRNAÒßÃç×î¿ÉžÍÊÇ»á¸Ä±ä±¾Ì壬ÎÒ´òÍêÒ»Õë¸Ð¾õ±äÇîÁË¡£
Ôõô½âÕâ¸ö£¿[lioncity_sg (6-20 10:13, Long ago)]
[ ´«Í³°æ |
sForum ][µÇ¼ºó»Ø¸´]55Â¥
¿ÆÐËpeer reviewed phase 3 dataÔÚÄIJ»Ì¸ÕþÖΠ̸ֻ¿Æѧ
¿ÆÐËÖ»·¢ÁËphase1£¬2µÄpaper£ºhttps://www.thelancet.com/article/S1473-3099(20)30843-4/fulltext
"No Phase 3 study data on the vaccine has yet been published in peer-reviewed journals."
ΪɶÍÏÁËÕâô¾Ã·¢²»³öphase 3µÄpaper
¹úÒ©£º"The WHO¡¯s approval of Sinopharm before the publication of peer-reviewed data reflected a measure of desperation "
»ÔÈðpaper£ºhttps://www.nejm.org/doi/full/10.1056/nejmoa2034577
ĪµÂÄÉpaper: https://www.nejm.org/doi/full/10.1056/nejmoa2035389[ICµÛ (6-20 10:20, Long ago)]
[ ´«Í³°æ |
sForum ][µÇ¼ºó»Ø¸´]56Â¥
(ÒýÓà ICµÛ:¿ÆÐËpeer reviewed phase 3 dataÔÚÄIJ»Ì¸ÕþÖΠ̸ֻ¿Æѧ
¿ÆÐËÖ»·¢ÁËphase1£¬2µÄpaper£ºhttps://www.thelancet.com/article/S1473-3099(20...)ÎÒÒ²¸Ðµ½Ææ¹Ö£¬µ«ÊÇ¿´µ½Ò»Ð©¹ú¼ÒºÍ×éÖ¯·¢µÄÓйؿÆÐ˵ÄÎÄÕ£¬
¸Ð¾õÊÇ֪ʶ²úȨ£¬Êý¾Ý¹²ÏíÎÊÌ⣬¼ÓÉϸ÷¹úÖƶ¨µÄÈýÆÚ±ê×¼²»Ò»£¬Ò»¸öͳһ±ê×¼µÄÈýÆÚ±¨¸æºÜÄÑ£¬
µ«ÊÀÎÀÅú×¼µÄÒÀ¾ÝÊÇʲô£¿
ûÓÐÈýÆÚÊý¾ÝÊÀÎÀÒ²¸ÒÅú×¼[lgland (6-20 10:32, Long ago)]
[ ´«Í³°æ |
sForum ][µÇ¼ºó»Ø¸´]57Â¥
(ÒýÓà lgland:ÎÒÒ²¸Ðµ½Ææ¹Ö£¬µ«ÊÇ¿´µ½Ò»Ð©¹ú¼ÒºÍ×éÖ¯·¢µÄÓйؿÆÐ˵ÄÎÄÕ£¬ ¸Ð¾õÊÇ֪ʶ²úȨ£¬Êý¾Ý¹²ÏíÎÊÌ⣬¼ÓÉϸ÷¹úÖƶ¨µÄÈýÆÚ±ê×¼²»Ò»£¬Ò»¸öͳһ±ê×¼µ...)̹°×˵£¬Õâʶù»Øµ½°Ë¾ÅÊ®Äê´úÉÏÊÀ¼Í£¬¿ÆÐËÔÙÀ÷º¦Ð§¹ûÔٺã¬WHOÒ²²»Ò»¶¨Åú»òÅúÕâÑù¿ì£»Ì쳯±Ï¾¹²»ÊÇÒÔÇ°µÄÌ쳯ÁË£¡¡£¡£¡£¡£¡£ [Blzrd (6-20 10:49, Long ago)] [ ´«Í³°æ | sForum ][µÇ¼ºó»Ø¸´]58Â¥
(ÒýÓà Blzrd:̹°×˵£¬Õâʶù»Øµ½°Ë¾ÅÊ®Äê´úÉÏÊÀ¼Í£¬¿ÆÐËÔÙÀ÷º¦Ð§¹ûÔٺã¬WHOÒ²²»Ò»¶¨Åú»òÅúÕâÑù¿ì£»Ì쳯±Ï¾¹²»ÊÇÒÔÇ°µÄÌ쳯ÁË£¡¡£¡£¡£¡£¡£
)ËùÒÔÏÖÔÚ¸÷Ë÷ËùÐ裬ÐèÒªµÄר¼ñÕýÃæÐÂÎÅ£¬
·´¶Ô×ÅÒ²¹â˵¸ºÃ汨µÀ£¬
µ«¿ÆÐ˵İٷÖÖ®ÎåÊ®¼¸µÄ±£»¤ÂÊ£¬»ù±¾ÉÏÊǸºÃæÓ°ÏìÏÂÏÞ£¬
¾ÍÊÇ˵֪µÀÁË×Çé¿ö£¬±ÈÖ»ÖªµÀ×îºÃÇé¿ö£¬ÇÒ²»¶Ï±¬ÏÂÏÞ£¬ÒªºÃ¡£[lgland (6-20 10:59, Long ago)]
[ ´«Í³°æ |
sForum ][µÇ¼ºó»Ø¸´]59Â¥
(ÒýÓà ICµÛ:¿ÆÐËpeer reviewed phase 3 dataÔÚÄIJ»Ì¸ÕþÖΠ̸ֻ¿Æѧ
¿ÆÐËÖ»·¢ÁËphase1£¬2µÄpaper£ºhttps://www.thelancet.com/article/S1473-3099(20...)ÈýÆÚ½á¹û¶¼¹«²¼ÁË°¡¿ÆÐË£º
Efficacy and Safety of a COVID-19 Inactivated Vaccine in Healthcare Professionals in Brazil: The PROFISCOV Study
https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3822780
¹úÒ©£¨ÈýÆÚinterim±¨¸æ£©£º
Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults A Randomized Clinical Trial
https://jamanetwork.com/journals/jama/fullarticle/2780562[»ªÐÂСºÅ163 (6-20 11:27, Long ago)]
[ ´«Í³°æ |
sForum ][µÇ¼ºó»Ø¸´]60Â¥